We are live on ! Find out more
FIS

FCPM III Services Portfolio holdings

AUM $722M
1-Year Est. Return 73.61%
This Fund
S&P 500
This Quarter Est. Return
-28.79%
1 Year Est. Return
+73.61%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$414M
AUM Growth
-$179M
Cap. Flow
+$10.7M
Cap. Flow %
2.58%
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
2
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
NAMS icon
NewAmsterdam Pharma
NAMS
+$7.52M
2
ATXS
Astria Therapeutics
ATXS
+$6.65M

Top Sells

Rank Stock Value
1
ACHL
Achilles Therapeutics
ACHL
+$2.75M
2
REPL icon
Replimune Group
REPL
+$755K

Sector Composition

Rank Sector Weight
1 Healthcare 99.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NAMS icon
1
NewAmsterdam Pharma
NAMS
$3.47B
$224M 54.11%
10,935,310
+338,129
+3% +$7.52M
DYN icon
2
Dyne Therapeutics
DYN
$3.88B
$57.1M 13.81%
5,462,846
– –
ENGN icon
3
enGene Therapeutics
ENGN
$125M
$43.2M 10.43%
9,632,561
– –
REPL icon
4
Replimune Group
REPL
$882M
$38.1M 9.21%
3,909,696
-60,972
-2% -$755K
BCYC
5
Bicycle Therapeutics
BCYC
$290M
$29.3M 7.08%
3,452,330
– –
ATXS
6
DELISTED
Astria Therapeutics
ATXS
$20.4M 4.93%
3,822,537
+950,000
+33% +$6.65M
ENGNW icon
7
enGene Therapeutics Warrants
ENGNW
$3.53M
$1.73M 0.42%
2,878,148
– –
ACHL
8
DELISTED
Achilles Therapeutics
ACHL
– –
-2,390,050
Closed -$2.75M

Similar funds

ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return
ZAM
Zevin Asset Management Boston, Massachusetts $723M AUM 15.62% 1-Year Est. Return
AF
Apollon Financial Mount Pleasant, South Carolina $723M AUM 24.23% 1-Year Est. Return
UW
Unique Wealth Clearwater, Florida $723M AUM 16.35% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
FFM
FengHe Fund Management Singapore $724M AUM 196.18% 1-Year Est. Return
WLIM
White Lighthouse Investment Management Bedford, Massachusetts $721M AUM 16.12% 1-Year Est. Return

FCPM III Services's Q1 2025 Portfolio in Review

As of Q1 2025, FCPM III Services held 8 positions worth $414M, down 30% from $592M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

FCPM III Services's Q1 2025 filing shows 2 increased, 1 reduced and 1 closed positions. The largest sale was Achilles Therapeutics, an estimated $2.75M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, down from 100% a quarter earlier.

  • FCPM III Services added most to NewAmsterdam Pharma in Q1 2025, an estimated $7.52M increase.
  • FCPM III Services's biggest Q1 2025 reduction was Replimune Group, cutting an estimated $755K.
  • FCPM III Services fully exited Achilles Therapeutics in Q1 2025, selling an estimated $2.75M.
  • FCPM III Services's ten largest holdings make up 100% of its $414M portfolio in Q1 2025.
  • FCPM III Services opened 0 new positions and closed 1 in Q1 2025.
  • FCPM III Services's portfolio value fell 30% quarter-over-quarter to $414M.

Based on FCPM III Services's 13F filing for Q1 2025, filed 15 May 2025.